Anonymous
Guest
Anonymous
Guest
"Those guys have their heads in the sand--deep, real deep in the sand--when you consider their [R&D] productivity has been close to zero," Isaly said. He figures Lilly will need to spend billions to bring in new drugs: "They might have to shell out $20 billion or more to find the assets to tide them over."